| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Dir | 2.98M | $55.31M | - | |
| CEO | 929.4K | $17.23M | - | |
| CEO | 756.1K | $14.02M | - | |
| Dir | 214.4K | $3.97M | - | |
| Pres | 203.9K | $3.78M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Mar 16, 2016 | M Kathleen Behrens | Director | Buy | 75,000 | $16.28 | $1,220,708.50 | -141.1% | |
| Mar 14, 2016 | Richard Barry70 | Director | Buy | 75,000 | $15.66 | $1,174,185.00 | +2.4% | |
| Mar 14, 2016 | Ben Gil Price | Director | Buy | 4,500 | $16.70 | $75,144.15 | +11.7% | |
| Feb 27, 2015 | Edward M. Kaye MD45 | SVP & Chief Medical Officer | Buy | 800 | $11.82 | $9,452.00 | +156.6% | |
| Feb 27, 2015 | Nishan Garabedian Christopher | President and CEO | Buy | 800 | $11.82 | $9,452.00 | +2.8% |